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We previously discussed the possibility of transdermal ap-
plication of morphine hydrochloride (MPH)1—3) and exam-
ined a mixed solvent system containing water, ethanol
(EtOH) and l-menthol (LM) as a skin penetration-enhancing
system.4—8) The phase condition of the system markedly af-
fected the penetration enhancing effect.6) The saturated LM
in the applied aqueous solvent system was necessary to ob-
tain a strong enhancing effect, but an excessive amount of
LM, which made an o/w emulsion, decreased the enhancing
effect. When a finite amount of the system was applied to
skin, the system composition on skin changed over time due
to the high skin permeability of EtOH.9,10) The composition
change of the system must be considered to design a useful
transdermal delivery system containing water, EtOH and LM
as penetration enhancers.
In this study, a finite amount of the mixed solvent system
containing MPH, water, EtOH and LM were applied to ex-
cised hairless rat skin, and MPH, EtOH and LM permeation
was examined. 1,3-Butylene glycol (BG) was used as one
more component to control hydrophilicity or lipophilicity of
the mixed system.11) Five different formulas were used for
the application systems (Table 1). Three contained almost
saturated LM, and the initial content of LM in the rest was
below the limit of solubility of LM. Polyethyleneoxide E-45
(PEO) was used as a neutral polymer to increase viscosity of
the systems.
MATERIALS AND METHODS
Materials MPH and naloxone hydrochloride were pur-
chased from Takeda Pharmaceutical Co. (Osaka, Japan) and
Sigma Chemical Industries (St. Louis, MO, U.S.A.), respec-
tively. LM was purchased from Wako Pure Chemical Indus-
tries (Osaka). All other chemicals were of reagent grade and
were used without further purification.
In Vitro Skin Permeation Experiments The abdominal
skin of male WBN/ILA-Ht hairless rats (150—200 g,
Ishikawa Laboratory Animals, Saitama, Japan) was excised
and mounted in a vertical diffusion cell with a receiver vol-
ume of 2.8 ml and an effective diffusion area of 0.95 cm2.
The receiver cell was filled with distilled water and the cell
set was kept at 37 °C. Two hundred milligrams of each solu-
tion shown in Table 1 was applied to the skin. One milliliter
of receiver solution was withdrawn at predetermined times
for 24 h to determine concentrations of MPH, LM and EtOH.
The same volume of water was added to the receiver com-
partment to keep the volume constant.
Analysis The concentration of MPH was assayed by an
HPLC system (pump, LC-9A; UV detector, SPD-6A; Shi-
madzu Seisakusho, Kyoto, Japan). The column used was a
LiChrospher 100 RP-18(e) 5 mm (4.03250 mm, Kanto
Chemical Co., Tokyo, Japan). A mixture of 0.1% phosphoric
acid–acetonitrile (65 : 35) containing 5 mM sodium dodecyl-
sulfate was used as the mobile phase, and elution was per-
formed at 40 °C with a flow rate of 1.2 ml/min. Aliquots of
200 m l of the receiver solution were withdrawn and mixed
with the same volume of methanol containing naloxone hy-
drochloride as an internal standard, and then the mixture was
centrifuged at 5000 g for 10 min. Aliquots of the supernatant
(20 m l) were injected into the HPLC system. The UV detec-
tor was operated at 230 nm. 
Gas chromatography (GC) with a flame ionization detector
(GC-6A, Shimadzu Seisakusho) was used for determination
of LM and EtOH. OV-17 was used as the column and GC
was operated at a column temperature of 130°C, and injector
and detector temperature of 160°C for LM analysis. On the
other hand, Gasukuropak 54 was used as the column and GC
was operated at a column temperature of 140°C, and injector
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and detector temperature of 180 °C for EtOH analysis.
Aliquots of 200 m l of the receiver solution were mixed with
the same volume of dioxane containing n-propanol and l-car-
vone as internal standards for EtOH and LM, respectively,
and then the mixture was centrifuged at 5000 g for 10 min.
Aliquots of the supernatant (1 m l) were injected under each
condition for EtOH and LM.
RESULTS AND DISCUSSION
Five different solutions shown in Table 1 were used for ap-
plication of MPH. As LM is an essential oil, it is insoluble in
water. EtOH and BG act as solubilizers for LM. Since BG is
a little more hydrophilic than EtOH (the solubility parameter:
BG528.15 (J/cm3)1/2, EtOH526.14 (J/cm3)1/2), the replace-
ment of EtOH with BG makes the system more hy-
drophilic.11) However, the difference between EtOH and BG
in the solubilizing effect for LM was small. Five percents of
LM in the systems was solubilized when total content of
EtOH and BG was 50%. Therefore, three contained almost
saturated LM, and the initial content of LM in the rest was
below the limit of solubility of LM in the system.
Two hundred milligrams of each solution was applied to
the excised hairless rat skin and MPH, EtOH and LM skin
permeations were examined. The time course of permeation
flux of MPH is shown in Fig. 1. In the cases of application of
the LM-saturated systems, the maximum values of the flux
were observed within 4 h and the pseudo steady-state fluxes
gradually decreased thereafter. Although the EtOH/BG ratio
was different in the LM-saturated systems, MPH permeation
profiles from these systems were similar, suggesting a simi-
larity of EtOH and BG effect on the skin. On the other hand,
a lag time of about 2 h for the permeation of MPH was ob-
served following the application of LM-solubilized systems.
After the lag time, the flux of MPH increased rapidly. Al-
though the permeation profiles of MPH in the initial phase
were different, the maximum values of the flux and the per-
meation profiles in the following phase of MPH were similar
with application of all systems.
Our previous study showed that saturated LM in the ap-
plied system is necessary to obtain a strong enhancing
effect.6) In finite applications, the solubility of LM changed
due to the escape of permeable components such as EtOH
from the applied solutions into the skin, and thereby the ac-
tivity and penetration-enhancing effects of LM changed over
passing time. In addition, if a solvent drag effect of EtOH
contributed to enhancement of MPH permeation, the time
course of changes in the permeation rate of MPH would de-
pend on that of EtOH.12,13) The delayed enhancing effect with
application of LM-solubilized systems suggested that the ac-
tivity of LM and its changes in the applied solutions are im-
portant for the enhancing effect of the system. The perme-
ation of EtOH and LM through the skin was also determined
to understand the mode of action of the penetration enhanc-
ing systems. The profiles of the permeation rate of EtOH and
LM are shown in Figs. 2 and 3, respectively. The permeation
rates of EtOH were higher than those of MPH and LM. Com-
parison of the initial high permeation rates of EtOH from the
LM-saturated systems with that from the unsaturated systems
suggested a marked contribution of solvent drag of EtOH.
Although the maximum flux of EtOH permeation from the
LM-saturated systems was proportional to initial content of
EtOH in the systems and most of the EtOH applied had per-
meated through the skin within 10 h, however, the maximum
flux of MPH was independent of the initial content of EtOH
and the permeation of MPH continued beyond 10 h after the
application. Therefore, the contribution of the solvent drag
effect of EtOH to MPH permeation could be small in these
cases. In addition, since the initial EtOH permeation from the
LM-saturated systems was proportional to EtOH content and
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Table 1. Composition of the Solution for Application to the Skin 
Content (%)
Rp. # PC a)
EtOH BG LM MPH PEO
1 10 40 5 1 3 Sb)
2 20 30 5 1 3 S
3 20 40 5 1 3 Uc)
4 30 20 5 1 3 S
5 30 30 5 1 3 U
Water was added to 100%. a) Phase condition, b) LM-saturated, c) LM-unsaturated.
Fig. 1. Time Course of Changes in the Permeation Rate of MPH through
Excised Hairless Rat Skin
d; EtOH 10%, BG 40%, LM 5% (Rp. # 1 in Table 1): m; EtOH 20%, BG 30%, LM
5% (Rp. # 2 in Table 1): n; EtOH 20%, BG 40%, LM 5% (Rp. # 3 in Table 1): j;
EtOH 30%, BG 20%, LM 5% (Rp. # 4 in Table 1): h; EtOH 30%, BG 30%, LM 5%
(Rp. # 5 in Table 1). Points represent the means6S.D. (n53).
Fig. 2. Time Course of Changes in the Permeation Rate of EtOH through
Excised Hairless Rat Skin
d; EtOH 10%, BG 40%, LM 5% (Rp. # 1 in Table 1): m; EtOH 20%, BG 30%, LM
5% (Rp. # 2 in Table 1): n; EtOH 20%, BG 40%, LM 5% (Rp. # 3 in Table 1): j;
EtOH 30%, BG 20%, LM 5% (Rp. # 4 in Table 1): h; EtOH 30%, BG 30%, LM 5%
(Rp. # 5 in Table 1). Points represent the means6S.D. (n53).
was independent of BG content, the effect of BG on the per-
meation of EtOH may be small. The permeation of LM
through the skin from the LM-saturated systems was higher
than that from the LM-solubilized systems in the initial
phase and the permeation of LM in the later phase from the
all systems was similar. LM changes barrier function in the
stratum corneum.14,15) The continuous permeation of MPH in
the later phase could be related to that of LM. Amount of
LM migrated into the skin appeared to be the most important
parameter for the penetration-enhancing effect of the mixed
system in MPH permeation through excised hairless rat skin.
Since this study is incomplete and partial, complete mech-
anism on the penetration-enhancing effect of each compo-
nent and the interaction between the components have not
been understood yet. As demonstrated in this study, however,
changes in the composition of the applied solution should be
considered in the cases of finite application of enhancing sys-
tems containing EtOH and LM. In addition, the amount of
solution applied to skin should be related not only to bioavil-
ability16,17) of the drug applied but also to skin irritancy of
EtOH in the system.18) The composition and volume of drug-
reservoir solution should be optimized to design a useful
transdermal delivery system containing water, EtOH and LM
as penetration enhancers. For the optimization, additional
studies of enhancing mechanism in detail should be needed.
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Fig. 3. Time Course of Changes in the Permeation Rate of LM through
Excised Hairless Rat Skin
d; EtOH 10%, BG 40%, LM 5% (Rp. # 1 in Table 1): m; EtOH 20%, BG 30%, LM
5% (Rp. # 2 in Table 1): n; EtOH 20%, BG 40%, LM 5% (Rp. # 3 in Table 1): j;
EtOH 30%, BG 20%, LM 5% (Rp. # 4 in Table 1): h; EtOH 30%, BG 30%, LM 5%
(Rp. # 5 in Table 1). Points represent the means6S.D. (n53).
